The development of multispecific antibody has become a key technology because it allows multiple targeting, reduces toxicity, and brings immune effector cells into close proximity with cancer cells, ultimately enhancing therapeutic efficacy and preventing drug resistance. Creative Biolabs provides a full range of services of multispecific and
multifunctional immune checkpoint antibody development for our clients.